exposure.
The number of persons in the
Rongelap group is small and many werechildren
at the time of exposure, thereby introducing
sample size and age factor into the analysis.
Finally, variations in the thyroid-absorbed
radiation dose were primarily dependent on ageat
exposure, and therefore extensive destruction of

thyroid tissue with a consequent decrease in risk

of thyroid cancer may have occurred in the
youngerindividuals (NCRP, 1985).
One inference is extractable from the
Marshallese data by examining the ratios of
benign to malignant nodules (Table 3, column B).
The Utirik population, which received no

thyroxine suppression, had ratios of about 3.5:1 in

children less than age ten and 3.7:1 in older
children and adults, respectively. In the exposed
Utirik group over the age of 10 the numberof
carcinomas which developed was 3 and the
number of benign nodules was 11. On the other
hand, in the Rongelap group over the age of 10,
which was receiving thyroxine suppression, the
number of carcinomasthat developed was 4 and
the numberof benign nodules only 5 with a ratio
of 1.25:1. Based on the numberofthyroid cancers
in the Utirik group, the number of benign
Rongelap nodules in those exposed when they
were over 10 years of age should have been about
15. That the relatively low number of benign
nodules in this group was not the result of the
higher radiation dose is seen in the plethora of
benign nodules and the highest ratio of benign to
malignant nodules in Rongelap children underten
years ofage, all of whom received over 2000 cGy.
Thyroxine suppression mayhaveresultedin the
development of fewer benign nodules in the older
population.
(See above for the discussion
concerning the limitations of the validity of this
interpretation). It is not possible to determineif
thyroxine prevented the development of benign
nodules in Rongelap children under 10 years of
age, in part because 15 of the total of 18
adenomatous nodules in this group had been
detected within five years of starting suppression
therapy and therefore were unlikely to have been
much affected by prophylaxis. The incidence of
thyroid cancer in Rongelap persons over 10 years
of age was 7% and in the comparable Utirik
population persons 4%, The incidence in the
former might have even been higher without
thyroxine suppression but this will never be
proven.

9) Did fetal radiation exposure produce throid
nodules?

It is known that }941 given in pregnancy

can

produce hypothyroidism in the fetus (Fisher al.,
1963). Since the fetal thyroid begins to conce
iodine at about the twelfth week of pregnan
of fetal thyroid injury from radioiodines begi
this time. Those fetuses at the time of expos
BRAVOfallout received both a whole-body d
gamma radiation equal to their mothers’ a
radioiodine dose to the thyroid which wasa fu
of age of gestation, maternal radioiodine dose
the extent of placental transfer of the radioiso
The placenta is not a barrier to iodine tr
(Fisher, 1975).
Twelve persons followed by the Marshall Is
Medical Program were in utero at the ti
exposure, four from Rongelap and eight
Utirik. Three of these have now developed th
nodules: two of the four Rongelap children
one of the seven Utirik children (the eighth p
in the latter group has never been availabl
examination). Table 5 summarizes the in
exposure data.

since the thyroid doses were not calculated t
very high in two of the three (Nos. 3 and 8,
5). None of those irradiated in utero have bec@me
spontaneously hypothyroid. Since the extefnal
whole-body dose estimates are probably ffirly
accurate, it may be that the internalized dose Iwas
higher in the three persons with nodules than was
estimated. All the external and internal thygoid
doses calculated by Lessard et al. (1985) Were
derived from a variety of data on radiation soufces
and conditions, and that report states that [the
maximum thyroid-absorbed dose could have be
much as four times the mean values used he

developed cancers that appearedafter the age of 14
_ years. One of these was a thyroid cancer wifich
occurred in a person whosegestational age wag 22
weeks at exposure (Yoshimoto etal., 1988).

24

Select target paragraph3